Rhind S, Shiu M, Tenn C, Nakashima A, Jetly R, Sajja V
Int J Mol Sci. 2025; 26(5).
PMID: 40076437
PMC: 11898641.
DOI: 10.3390/ijms26051808.
Liu S, Li X, Jiang S, Liu D, Wang J
Int J Gen Med. 2025; 18:771-786.
PMID: 39967766
PMC: 11834669.
DOI: 10.2147/IJGM.S502086.
Banoei M, Hutchison J, Panenka W, Wong A, Wishart D, Winston B
Crit Care. 2025; 29(1):26.
PMID: 39815318
PMC: 11737060.
DOI: 10.1186/s13054-025-05258-1.
Rhind S, Shiu M, Vartanian O, Tenn C, Nakashima A, Jetly R
Int J Mol Sci. 2025; 25(24.
PMID: 39769446
PMC: 11728191.
DOI: 10.3390/ijms252413683.
Zhang Y, Savvidou M, Liaudanskaya V, Singh P, Fu Y, Nasreen A
Sci Adv. 2024; 10(50):eadp1980.
PMID: 39661671
PMC: 11633737.
DOI: 10.1126/sciadv.adp1980.
The Relationship between the Improvement Level in Blood Gas Parameters in Time and Brain MRI Findings in Newborns with the Diagnosis of Hypoxic Ischemic Encephalopathy.
Yilmaz A, Uygur A, Celik B, Akdag A, Baser D, Ozturk S
Turk Arch Pediatr. 2024; 59(6):553-559.
PMID: 39540752
PMC: 11562593.
DOI: 10.5152/TurkArchPediatr.2024.24152.
Repetitive subconcussion results in disrupted neural activity independent of concussion history.
Solar K, Ventresca M, Zamyadi R, Zhang J, Jetly R, Vartanian O
Brain Commun. 2024; 6(5):fcae348.
PMID: 39440300
PMC: 11495223.
DOI: 10.1093/braincomms/fcae348.
Integrated Assessment of GFAP and UCH-L1 for their utility in severity assessment and outcome prediction in Traumatic Brain Injury.
Mathew D, Purohit P, Gadwal A, Anil A, Kumar Sharma R, Meshram V
Int J Legal Med. 2024; 138(6):2559-2568.
PMID: 38977505
DOI: 10.1007/s00414-024-03287-z.
Prediction Value of Initial Serum Levels of SERPINA3 in Intracranial Pressure and Long-Term Neurological Outcomes in Traumatic Brain Injury.
Tan H, Wang J, Li F, Peng Y, Lan J, Zhang Y
Diagnostics (Basel). 2024; 14(12).
PMID: 38928660
PMC: 11202773.
DOI: 10.3390/diagnostics14121245.
Turbulent dynamics and whole-brain modeling: toward new clinical applications for traumatic brain injury.
Martinez-Molina N, Sanz-Perl Y, Escrichs A, Kringelbach M, Deco G
Front Neuroinform. 2024; 18:1382372.
PMID: 38590709
PMC: 10999628.
DOI: 10.3389/fninf.2024.1382372.
ENIGMA's simple seven: Recommendations to enhance the reproducibility of resting-state fMRI in traumatic brain injury.
Caeyenberghs K, Imms P, Irimia A, Monti M, Esopenko C, de Souza N
Neuroimage Clin. 2024; 42:103585.
PMID: 38531165
PMC: 10982609.
DOI: 10.1016/j.nicl.2024.103585.
Unveiling the Intricacies: A Comprehensive Review of Magnetic Resonance Imaging (MRI) Assessment of T2-Weighted Hyperintensities in the Neuroimaging Landscape.
Dhabalia R, Kashikar S, Parihar P, Mishra G
Cureus. 2024; 16(2):e54808.
PMID: 38529430
PMC: 10961652.
DOI: 10.7759/cureus.54808.
Neuroinflammation and acquired traumatic CNS injury: a mini review.
Theus M
Front Neurol. 2024; 15:1334847.
PMID: 38450073
PMC: 10915049.
DOI: 10.3389/fneur.2024.1334847.
Serum biomarkers of hypoxic-ischemic brain injury.
Tefr Faridova A, Herman H, Danacikova S, Svoboda J, Otahal J
Physiol Res. 2024; 72(S5):S461-S474.
PMID: 38165751
PMC: 10861251.
DOI: 10.33549/physiolres.935214.
Spatiotemporal profile of atrophy in the first year following moderate-severe traumatic brain injury.
Brennan D, Duda J, Ware J, Whyte J, Choi J, Gugger J
Hum Brain Mapp. 2023; 44(13):4692-4709.
PMID: 37399336
PMC: 10400790.
DOI: 10.1002/hbm.26410.
Mass Spectrometry-Based Approaches for Clinical Biomarker Discovery in Traumatic Brain Injury.
Creech M, Carvalho L, McCoy H, Jacobs J, Hinson H
Curr Treat Options Neurol. 2023; 24(12):605-618.
PMID: 37025501
PMC: 10072855.
DOI: 10.1007/s11940-022-00742-3.
Multi-Mechanistic Approaches to the Treatment of Traumatic Brain Injury: A Review.
Lynch D, Narayan R, Li C
J Clin Med. 2023; 12(6).
PMID: 36983181
PMC: 10052098.
DOI: 10.3390/jcm12062179.
Systematic Review of the Diagnostic and Clinical Utility of Salivary microRNAs in Traumatic Brain Injury (TBI).
Hiskens M, Mengistu T, Li K, Fenning A
Int J Mol Sci. 2022; 23(21).
PMID: 36361944
PMC: 9654991.
DOI: 10.3390/ijms232113160.
Neuroimaging Markers for Determining Former American Football Players at Risk for Alzheimer's Disease.
Baragi V, Gattu R, Trifan G, Woodard J, Meyers K, Halstead T
Neurotrauma Rep. 2022; 3(1):398-414.
PMID: 36204386
PMC: 9531889.
DOI: 10.1089/neur.2022.0020.
Prognostic Value of Serum Procalcitonin Based Model in Moderate to Severe Traumatic Brain Injury Patients.
Wang R, Hua Y, He M, Xu J
J Inflamm Res. 2022; 15:4981-4993.
PMID: 36065318
PMC: 9440674.
DOI: 10.2147/JIR.S358621.